Literature DB >> 24563482

Myocilin regulates cell proliferation and survival.

Myung Kuk Joe1, Heung Sun Kwon, Radu Cojocaru, Stanislav I Tomarev.   

Abstract

Myocilin, a causative gene for open angle glaucoma, encodes a secreted glycoprotein with poorly understood functions. To gain insight into its functions, we produced a stably transfected HEK293 cell line expressing myocilin under an inducible promoter and compared gene expression profiles between myocilin-expressing and vector control cell lines by a microarray analysis. A significant fraction of differentially expressed genes in myocilin-expressing cells was associated with cell growth and cell death, suggesting that myocilin may have a role in the regulation of cell growth and survival. Increased proliferation of myocilin-expressing cells was demonstrated by the WST-1 proliferation assay, direct cell counting, and immunostaining with antibodies against Ki-67, a cellular proliferation marker. Myocilin-containing conditioned medium also increased proliferation of unmodified HEK293 cells. Myocilin-expressing cells were more resistant to serum starvation-induced apoptosis than control cells. TUNEL-positive apoptotic cells were dramatically decreased, and two apoptotic marker proteins, cleaved caspase 7 and cleaved poly(ADP-ribose) polymerase, were significantly reduced in myocilin-expressing cells as compared with control cells under apoptotic conditions. In addition, myocilin-deficient mesenchymal stem cells exhibited reduced proliferation and enhanced susceptibility to serum starvation-induced apoptosis as compared with wild-type mesenchymal stem cells. Phosphorylation of ERK1/2 and its upstream kinases, c-Raf and MEK, was increased in myocilin-expressing cells compared with control cells. Elevated phosphorylation of ERK1/2 was also observed in the trabecular meshwork of transgenic mice expressing 6-fold higher levels of myocilin when compared with their wild-type littermates. These results suggest that myocilin promotes cell proliferation and resistance to apoptosis via the ERK1/2 MAPK signaling pathway.

Entities:  

Keywords:  Apoptosis; Cell Growth; Cell Proliferation; Cell Signaling; ERK; Mesenchymal Stem Cells

Mesh:

Substances:

Year:  2014        PMID: 24563482      PMCID: PMC3974985          DOI: 10.1074/jbc.M113.547091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex.

Authors:  Myung Kuk Joe; Changwon Kee; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2012-02-25       Impact factor: 5.157

2.  Myocilin, a glaucoma-associated protein, promotes cell migration through activation of integrin-focal adhesion kinase-serine/threonine kinase signaling pathway.

Authors:  Heung Sun Kwon; Stanislav I Tomarev
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

Review 3.  ERK implication in cell cycle regulation.

Authors:  Jean-Claude Chambard; Renaud Lefloch; Jacques Pouysségur; Philippe Lenormand
Journal:  Biochim Biophys Acta       Date:  2006-11-17

4.  Myocilin, a component of a membrane-associated protein complex driven by a homologous Q-SNARE domain.

Authors:  W Michael Dismuke; Brian S McKay; W Daniel Stamer
Journal:  Biochemistry       Date:  2012-04-18       Impact factor: 3.162

Review 5.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Ellis W T Wong; Fumin Chang; Brian Lehmann; David M Terrian; Michele Milella; Agostino Tafuri; Franca Stivala; Massimo Libra; Jorg Basecke; Camilla Evangelisti; Alberto M Martelli; Richard A Franklin
Journal:  Biochim Biophys Acta       Date:  2006-10-07

Review 6.  Primary open-angle glaucoma.

Authors:  Young H Kwon; John H Fingert; Markus H Kuehn; Wallace L M Alward
Journal:  N Engl J Med       Date:  2009-03-12       Impact factor: 91.245

Review 7.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

8.  Transcription factor achaete scute-like 2 controls intestinal stem cell fate.

Authors:  Laurens G van der Flier; Marielle E van Gijn; Pantelis Hatzis; Pekka Kujala; Andrea Haegebarth; Daniel E Stange; Harry Begthel; Maaike van den Born; Victor Guryev; Irma Oving; Johan H van Es; Nick Barker; Peter J Peters; Marc van de Wetering; Hans Clevers
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

9.  A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow.

Authors:  Masoud Soleimani; Samad Nadri
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma.

Authors:  Yu Zhou; Oleg Grinchuk; Stanislav I Tomarev
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

View more
  10 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

2.  Mutated myocilin and heterozygous Sod2 deficiency act synergistically in a mouse model of open-angle glaucoma.

Authors:  Myung Kuk Joe; Naoki Nakaya; Mones Abu-Asab; Stanislav I Tomarev
Journal:  Hum Mol Genet       Date:  2015-03-03       Impact factor: 6.150

3.  Structural basis for misfolding in myocilin-associated glaucoma.

Authors:  Rebecca K Donegan; Shannon E Hill; Dana M Freeman; Elaine Nguyen; Susan D Orwig; Katherine C Turnage; Raquel L Lieberman
Journal:  Hum Mol Genet       Date:  2014-12-18       Impact factor: 6.150

Review 4.  Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma.

Authors:  Ian D Danford; Lana D Verkuil; Daniel J Choi; David W Collins; Harini V Gudiseva; Katherine E Uyhazi; Marisa K Lau; Levi N Kanu; Gregory R Grant; Venkata R M Chavali; Joan M O'Brien
Journal:  Prog Retin Eye Res       Date:  2017-02-20       Impact factor: 21.198

5.  Myocilin Gene Mutation Induced Autophagy Activation Causes Dysfunction of Trabecular Meshwork Cells.

Authors:  Xuejing Yan; Shen Wu; Qian Liu; Ying Cheng; Jingxue Zhang; Ningli Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-09

6.  A knowledge-based T2-statistic to perform pathway analysis for quantitative proteomic data.

Authors:  En-Yu Lai; Yi-Hau Chen; Kun-Pin Wu
Journal:  PLoS Comput Biol       Date:  2017-06-16       Impact factor: 4.475

7.  Myocilin Regulates Metalloprotease 2 Activity Through Interaction With TIMP3.

Authors:  Myung Kuk Joe; Raquel L Lieberman; Naoki Nakaya; Stanislav I Tomarev
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

8.  A Novel Luciferase Assay For Sensitively Monitoring Myocilin Variants in Cell Culture.

Authors:  Serena Zadoo; Annie Nguyen; Gulab Zode; John D Hulleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

9.  A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma.

Authors:  Jonathan S Myers; Kenneth N Sall; Harvey DuBiner; Natanya Slomowitz; William McVicar; Cadmus C Rich; Rudolf A Baumgartner
Journal:  J Ocul Pharmacol Ther       Date:  2016-03-22       Impact factor: 2.671

Review 10.  Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork (Review).

Authors:  Hongwei Wang; Mingzhe Li; Zhenzhen Zhang; Haifeng Xue; Xing Chen; Yong Ji
Journal:  Int J Mol Med       Date:  2018-11-20       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.